Energizer Medicine-B (02595): Hong Kong public offering oversubscribed by 2662.79 times, net proceeds from global offering approximately 1.67 billion Hong Kong dollars.

Jin Fang Pharmaceuticals-B (02595) announces the results of its distribution. The company globally sold 89.24 million shares, with 8.7% sold in Hong Kong and 91.3% sold internationally. The sale price per share was HK$20.39, raising approximately HK$1.67 billion in net proceeds. Each lot consists of 200 shares, and it is expected that the H shares will begin trading on the Hong Kong Stock Exchange on Friday, September 19, 2025 at 9:00 a.m. The Hong Kong public offering was oversubscribed by 2662.79 times, while the international offering was oversubscribed by 39.05 times.